Characterization of the kynurenine pathway in human oligodendrocytes

International Congress Series

Volumn 1304, Issue , 2007, Pages 213-217

  Lim, Chai K ^a   Smythe, George A ^b   Stocker, Roland ^b   Brew, Bruce J ^a   Guillemin, Gilles J ^a,b  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Human oligodendrocyte; Kynurenine pathway

Indexed keywords

EID: 35948944864     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.ics.2007.07.011     Document Type: Article

References (15)

1. Stone T.W. Neuropharmacology of quinolinic and kynurenic acids. Pharmacol. Rev. 45 (1993) 309-379
2. Wilson H.C., Onischke C., and Raine C.S. Human oligodendrocyte precursor cells in vitro: phenotypic analysis and differential response to growth factors. Glia 44 (2003) 153-165
3. Buntinx M., et al. Characterization of three human oligodendroglial cell lines as a model to study oligodendrocyte injury: morphology and oligodendrocyte-specific gene expression. J. Neurocytol. 32 (2003) 25-38
4. Guillemin G.J., et al. Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection. J. Neurochem. 78 (2001) 842-853
5. Christen S., et al. Inhibition by interferon-gamma of human mononuclear cell-mediated low density ipoprotein oxidation. Participation of tryptophan metabolism along the kynurenine pathway. J. Clin. Invest. 93 (1994) 2149-2158
6. Smythe G.A., et al. Concurrent quantification of quinolinic, picolinic and nicotinic acids using electron-capture negative-ion gas chromatography-mass spectrometry. Anal. Biochem. 301 (2002) 21-26
7. Hartai Z., et al. Kynurenine metabolism in multiple sclerosis. Acta Neurol. Scand. 112 (2005) 93-96
8. Mellor A.L., and Munn D.H. Tryptophan catabolism and regulation of adaptive immunity. J. Immunol. 170 (2005) 5809-5813
9. Wejksza K., et al. Demonstration of kynurenine aminotransferases I and II and characterization of kynurenic acid synthesis in oligodendrocyte cell line (OLN-93). Neurochem. Res. 30 (2005) 963-968
10. Rudzite V., et al. Serum tryptophan, kynurenine, and neopterin in patients with Guillain-Barre-syndrome (GBS) and multiple sclerosis (MS). Adv. Exp. Med. Biol. 398 (1996) 183-187
11. Sakurai K., et al. Effect of indoleamine 2,3-dioxygenase on induction of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 129 (2002) 186-196
12. Kwidzinski E., et al. Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation. FASEB J. 19 (2005) 1347-1349
13. Rejdak K., et al. Decreased level of kynurenic acid in cerebrospinal fluid of relapsing-onset multiple sclerosis patients. Neurosci. Lett. 331 (2002) 63-65
14. Okuno E., Nakamura M., and Schwarcz R. Two kynurenine aminotransferases in human brain. Brain Res. 542 (1991) 307-312
15. Guidetti P., Okuno E., and Schwarcz R. Characterization of rat brain kynurenine aminotransferases I and II. J. Neurosci. Res. 50 (1997) 457-465